Year To Quarter End Consolidated Statement Of Income

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7252380

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
53,865,000,000 JPY
206,103,000,000 JPY
259,594,000,000 JPY
259,968,000,000 JPY
172,269,000,000 JPY
-374,000,000 JPY
228,040,000,000 JPY
49,324,000,000 JPY
-105,000,000 JPY
149,221,000,000 JPY
227,934,000,000 JPY
178,715,000,000 JPY
Cost of sales
164,865,000,000 JPY
104,262,000,000 JPY
89,589,000,000 JPY
146,551,000,000 JPY
Gross profit (loss)
94,729,000,000 JPY
68,007,000,000 JPY
59,632,000,000 JPY
81,383,000,000 JPY
Selling, general and administrative expenses
Depreciation
1,234,000,000 JPY
1,118,000,000 JPY
Amortization of goodwill
1,010,000,000 JPY
3,411,000,000 JPY
4,422,000,000 JPY
967,000,000 JPY
4,229,000,000 JPY
3,262,000,000 JPY
Selling, general and administrative expenses
71,486,000,000 JPY
44,319,000,000 JPY
39,673,000,000 JPY
63,735,000,000 JPY
Operating profit (loss)
449,000,000 JPY
27,216,000,000 JPY
23,242,000,000 JPY
27,666,000,000 JPY
23,688,000,000 JPY
-4,423,000,000 JPY
21,901,000,000 JPY
11,000,000 JPY
-4,253,000,000 JPY
19,958,000,000 JPY
17,647,000,000 JPY
21,889,000,000 JPY
Non-operating income
Interest income
221,000,000 JPY
97,000,000 JPY
Dividend income
11,000,000 JPY
9,000,000 JPY
Non-operating income
4,921,000,000 JPY
5,302,000,000 JPY
8,103,000,000 JPY
8,111,000,000 JPY
Non-operating expenses
Interest expenses
1,627,000,000 JPY
1,346,000,000 JPY
768,000,000 JPY
947,000,000 JPY
Non-operating expenses
2,011,000,000 JPY
1,457,000,000 JPY
830,000,000 JPY
1,282,000,000 JPY
Ordinary profit (loss)
26,152,000,000 JPY
27,532,000,000 JPY
27,231,000,000 JPY
24,477,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
275,000,000 JPY
0 JPY
0 JPY
313,000,000 JPY
Extraordinary income
275,000,000 JPY
0 JPY
0 JPY
313,000,000 JPY
Extraordinary losses
Impairment losses
12,000,000 JPY
19,000,000 JPY
Extraordinary losses
96,000,000 JPY
68,000,000 JPY
257,000,000 JPY
331,000,000 JPY
Profit (loss) before income taxes
26,330,000,000 JPY
27,464,000,000 JPY
26,974,000,000 JPY
24,459,000,000 JPY
Income taxes - current
8,058,000,000 JPY
6,838,000,000 JPY
7,551,000,000 JPY
8,818,000,000 JPY
Income taxes - deferred
-715,000,000 JPY
-474,000,000 JPY
-177,000,000 JPY
-532,000,000 JPY
Income taxes
7,343,000,000 JPY
6,363,000,000 JPY
7,374,000,000 JPY
8,286,000,000 JPY
Profit (loss)
21,100,000,000 JPY
18,986,000,000 JPY
21,100,000,000 JPY
21,100,000,000 JPY
21,100,000,000 JPY
19,600,000,000 JPY
19,600,000,000 JPY
19,600,000,000 JPY
16,173,000,000 JPY
19,600,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
18,986,000,000 JPY
18,986,000,000 JPY
18,986,000,000 JPY
16,173,000,000 JPY
16,173,000,000 JPY
16,173,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
37,000,000 JPY
84,000,000 JPY
Foreign currency translation adjustment
-378,000,000 JPY
5,691,000,000 JPY
Other comprehensive income
-341,000,000 JPY
5,776,000,000 JPY
Comprehensive income
18,645,000,000 JPY
21,949,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
18,645,000,000 JPY
21,949,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.